Abstract
Background:
Cellular senescence, characterized by irreversible cell cycle arrest, plays a pivotal role in ageing and the development of age-related pathologies. Mitigating oxidative stress, a primary contributor to cellular ageing, is crucial for inhibiting the senescence-associated secretory phenotype (SASP). A comparative analysis of synthetic and natural antioxidants is necessary to evaluate the efficacy of synthetic and natural antioxidants in this context.
Method:
A systematic review encompassed studies published up to July 2023, utilizing prominent databases such as PubMed, Google Scholar, Scopus, and Web of Science. To enhance the efficiency of data screening and selection, we employed Rayyan. ai, an advanced tool designed for systematic reviews.
Result:
The review encompassed 33 studies examining the impact of diverse antioxidants on cellular senescence. Findings indicated that synthetic antioxidants, such as N-acetylcysteine, and natural alternatives, like Vitamin C, demonstrated efficacy in attenuating oxidative stress and senescence markers. Notably, natural antioxidants frequently exhibited comparable or superior efficacy to their synthetic counterparts in most studies. Furthermore, the synergistic effects of antioxidant combinations sometimes yield enhanced benefits. It is worth noting that certain recently developed synthetic compounds, such as MHY2233, have shown promising results, exhibiting greater potency than established antioxidants in mitigating senescence markers.
Conclusion:
Dietary practices and the aging process can influence these intricate processes and how they interact, serving as potential primary and secondary preventative strategies. The Mediterranean diet, dietary antioxidants, and limiting calorie intake are promising nutritional strategies. Better insight into the molecular mechanisms of aging may facilitate the development of efficient biomarkers and antioxidants for diagnosis or treatment.
Systematic Review Registration:
1 Introduction
Cellular ageing or senescence, a process that induces irreversible cell cycle arrest, is a cellular response to various stresses (Qian and Chen, 2010). It is known as an important factor in tumor suppression and ageing (Parrinello et al., 2003), and age-related diseases such as osteoarthritis (Martin et al., 2004), glaucoma (Liton et al., 2005) the diabetic pancreas (Shimizu et al., 2012), and neurodegenerative disorders (Chen, 2000). Thus, it is a possible therapeutic target for age-related conditions (Childs et al., 2015). Cellular senescence can be classified depending on its inducing factors into replicative senescence (RS), stress-induced premature senescence (SIPS), drug-induced senescence, and oncogene-induced ageing (Dierick et al., 2002).
When cells enter the senescent stage, growth is arrested, cells undergo dramatic morphological changes, and they express senescence markers such as senescence-associated β-galactosidase (SA-β-gal), p16INK4, p53, and p21, which leads to the formation of DNA segments with chromatin alterations reinforcing senescence (DNA-SCARS) (Campisi, 2013; Giordano and Terlecky, 2012). Recently, it has been demonstrated that senescent cells express the senescence-associated secretory phenotype (SASP), which is released into the environment and impacts the functions of neighboring cells (Coppe et al., 2010). The SASP includes various transcription factors, growth factors, proinflammatory cytokines, including Interleukin (IL)-1, IL-6, and IL-8, proteases, and matrix metalloproteinases (Rodier and Campisi, 2011). Since many of these molecules are proinflammatory, SASP production could potentially provoke inflammation and play a significant role in numerous age-related diseases such as Alzheimer’s (Bagyinszky et al., 2017). Ageing cells accumulate DNA damage, which may result in irreversible growth arrest (Lim, 2006). Cell cycle checkpoints sense damage to the DNA structure and trigger complex cellular repair responses. If the DNA cannot be repaired effectively, cells go into permanent cell cycle arrest and apoptosis. A permanent cell cycle arrest occurs with cells remaining in the G0/G1 phase during senescence (Bartek and Lukas, 2001).
It has been reported that many signalling pathways, such as the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR), p53-p21, and p16-pRb, mainly regulate cellular ageing (Liu and Sabatini, 2020; Legrain et al., 2014). Several causes are important in cell aging, including glycation, mutation, protein aggregation, telomere shortening, and oxidative stress (Hayflick, 2007; Liochev, 2015). It has been suggested that telomere shortening is an important mechanism in cellular ageing (Passos and von Zglinicki, 2005). DNA damage is associated with the modulation of mammalian Sirtuin (SIRT), nicotinamide adenosine dinucleotide (NAD)-dependent protein deacetylase, which regulates multiple cellular processes, including senescence, metabolism, and cell cycle (Ma et al., 2019; Watroba et al., 2017). SIRT modulates cellular senescence through the deacetylation of various signalling molecules, such as Nuclear Factor-κB (NF-κB), forkhead box O (FOXO), and p53 (Inoue et al., 2007).
Oxidative stress is an important cause of cellular ageing and may lead to pathological damage to cells and cell death (Hayflick, 2007; Liochev, 2015). Oxidative stress can cause DNA damage, including DNA double-strand breaks, promote phosphorylation of γ-H2AX, activate ATM kinase activity, upregulate p53/p21 activity, and initiate cellular ageing (Rai et al., 2009). According to Denhan Harman’s oxidative stress theory of ageing, cells undergo ageing due to oxidative stress caused by free radicals (Harman, 1956). When the production of free radicals and reactive oxygen species (ROS) exceeds the capacity of the cells' antioxidant mechanisms, oxidative stress usually occurs (Liu et al., 2014). This phenomenon leads to oxidative damage to macromolecules like proteins, lipids, and DNA, contributing to cellular dysfunction and the progression of cell ageing (Colavitti and Finkel, 2005).
Antioxidants are compounds that interact with reactive oxygen species and their derivatives to prevent them from harming the cells. They are classified according to their sources into two main groups: synthetic and natural antioxidants (Amarachukwu Uzombah, 2022). Synthetic antioxidants are synthesized artificially by combinations of chemical substances. They are chemically synthesized compounds since they do not occur in nature and are added to food as preservatives to help prevent lipid oxidation (Atta et al., 2017). Natural antioxidants, explicitly derived from food and medicinal plants, including fruits, vegetables, spices, cereals, and traditional botanicals, may be considered bioactive compounds (Xu et al., 2017; Deng et al., 2012). Natural antioxidants in foods seem to provide metabolic benefits and are associated with a lower risk of developing several health problems (Comert and Gokmen, 2018). Furthermore, the protective effects of antioxidants in fruits and vegetables are related to three main groups: carotenoids, phenolic compounds, and vitamins (Thaipong et al., 2006).
The defense against oxidants declines during the ageing process (Muthuswamy et al., 2006), and it can be enhanced by supplementing antioxidants (Kumaran et al., 2009). Antioxidants consistently inhibit the induction of senescence phenotypes and increasing antioxidant defenses delays ageing by lowering oxidative stress (Nestelbacher et al., 2000; Agarwal et al., 2005). They are important to prevent cellular ageing (Syslova et al., 2014). Antioxidant production may be an effective, preventive, and therapeutic method for the ageing process (He et al., 2019; Zamora-Ros et al., 2010). Few systematic reviews have conducted precise comparisons between synthetic and natural antioxidants. This systematic review aims to critically compare the efficacy, mechanisms, and translational relevance of synthetic versus natural antioxidants in mitigating cellular senescence, with the goal of identifying promising candidates and therapeutic strategies for age-related interventions.
2 Methods
The current study is a systematic review and meta-analysis that adheres to the principles outlined in the PRISMA checklist (Moher et al., 2009). The study protocol has been registered within the Open Science Framework (OSF) (DOI: 10.17605/OSF.IO/B67WM).
2.1 Search strategy
In this systematic review, we conducted a comprehensive literature search across four significant databases: PubMed, Google Scholar, Scopus, and Web of Science (ISI). Up to July 2023, we identified 6,507 original articles. The search strategy and keywords used in each database are detailed in Table 1.
TABLE 1
| Data base | Search strategy |
|---|---|
| PubMed | “Synthetic antioxidants” [tiab] OR “Natural antioxidants” [tiab] OR “antioxidants” [tiab] OR “BHA” [tiab] OR “butylated hydroxyanisole” [tiab] OR “BHT” [tiab] OR “butylated hydroxytoluene” [tiab] OR “PG” [tiab] OR “Propyl Gallate” [tiab] OR “OG” [tiab] OR “Octyl Gallate” [tiab] OR “DG” [tiab] OR “Dodecyl Gallate” [tiab] OR “EDTA” [tiab] OR “Ethylenediaminetetraacetat” [tiab] OR “Ethylenediaminetetraacetic acid” [tiab] OR “TBHQ” [tiab] OR “tertiary butylhydroquinone” [tiab] OR “Acetylcysteine” [tiab] OR “Tocopherols” [tiab] OR “Ascorbic Acid” [tiab] OR “Rosemary extract” [tiab] OR “Anthocyanins” [tiab] OR “Lycopene” [tiab] OR “Carotenoids” [tiab] OR “Flavonoid” [tiab] OR “Vitamin C” [tiab] OR “Vitamin E” [tiab] OR “Tocopherol” [tiab] OR “tocotrienols” [tiab] OR “Vitamin A” [tiab] OR “Carotenoids” [tiab] OR “Carotene” [tiab] OR “Zeaxanthin” [tiab] OR “Lutein” [tiab] OR “Lycopene” [tiab] OR “beta-Cryptoxanthin” [tiab] OR “beta cryptoxanthin” [tiab] OR “Polyphenols” [tiab] OR “flavonols” [tiab] OR “flavanols” [tiab] OR “Catechins” [tiab] OR “actocyanins” [tiab] OR “isoflavones” [tiab] OR “Phenolic acids” [tiab] OR 2 “Phenolics” [tiab] OR “trace elements” [tiab] OR “selenium” [tiab] OR “Zinc” [tiab] OR “Ellagic acid” [tiab] OR “gallic acid” [tiab] OR “3,4,5-trihydroxybenzoic acid” [tiab] OR “protocatechuic” [tiab] OR “p-hydroxybenzoic acids” [tiab] OR “melanoidins” [tiab] OR “anthocyanins” [tiab] OR “Thymoquinone” [tiab] OR “Carvacrol” [tiab] OR “t-anethole” [tiab] OR “4-terpineol” [tiab] OR “Sesamin sesamolin” [tiab] OR “Curcumin” [tiab] OR “Monoterpenoid” [tiab] OR “Linalool” [tiab] OR “beta-carotene” [tiab] OR “beta carotene” [tiab] 686831 results 2- “Cellular aging” [tiab] OR “Erythrocyte Aging” [tiab] OR “Senescence-Associated secretory phenotype” [tiab] OR “Telomere shortening” [tiab] OR “cellular senescence” [Me SH] 30406 results ≠ 1 AND ≠ 2 |
| WOS | ((TS=(“synthetic antioxidant”) OR TS=(“synthetic antioxidants”) OR TS=(BHA) OR TS=(“butylated hydroxyanisole”) OR TS=(BHT) OR TS=(“butylated hydroxytoluene”) OR TS=(PG) OR TS=(“Propyl Gallate”) OR TS=(OG) OR TS=(“Octyl Gallate”) OR TS=(DG) OR TS=(“Dodecyl Gallate”) OR TS=(EDTA) OR TS=(“Ethylenediamine tetra acetate”) OR TS=(“Ethylenediaminetetraacetic acid”) OR TS=(TBHQ) OR TS=(“tertiary butylhydroquinone”) OR TS=(Acetylcysteine)) OR (TS=(“natural food derived antioxidants”) OR TS=(“natural food-derived antioxidants”) OR TS=(“natural food derived antioxidant”) OR TS=(“natural food-derived antioxidant”) OR TS=(“natural antioxidants”) OR TS=(“natural antioxidant”) OR TS=(Tocopherol*) OR TS=(“Ascorbic Acid”) OR TS=(“Rosemary Extract”) OR TS=(Anthocyanin*) OR TS=(lycopene) OR TS=(Carotenoid*) OR TS=(Flavonoid*) OR TS=(“Vitamin C″) OR TS=(“ascorbic acid”) OR TS=(ascorbate) OR TS=(“Vitamin E”) OR TS=(tocopherol*) OR TS=(tocotrienol*) OR TS=(“Vitamin A″) OR TS=(Carotenoid*) OR TS=(carotene*) OR TS=(zeaxanthin) OR TS=(lutein) OR TS=(lycopene) OR TS=(β-cryptoxanthin) OR TS=(“beta cryptoxanthin”) OR TS=(Polyphenol*) OR TS=(flavonol*) OR TS=(flavanol*) OR TS=(catechin*) OR TS=(anthocyanin*) OR TS=(isoflavone*) OR TS=(“phenolic acid”) OR TS=(“phenolic acids”) OR TS=(Phenolic*) OR TS=(“Trace elements”) OR TS=(selenium) OR TS=(zinc) OR TS=(“Ellagic acid”) OR TS=(“gallic acid”) OR TS=(“3,4,5-trihydroxybenzoic acid”) OR TS=(protocatechuic) OR TS=(“p-hydroxybenzoic acid”) OR TS=(“p-hydroxybenzoic acids”) OR TS=(melanoidin*) OR TS=(Anthocyanin*) OR TS=(Thymoquinone) OR TS=(carvacrol) OR TS=(t-anethole) OR TS=(4-terpineol) OR TS=(“Sesamin sesamolin”) OR TS=(Curcumin) OR TS=(Monoterpenoid*) OR TS=(Linalool) OR TS=(β-carotene*) OR TS=(“beta carotene”) OR TS=(“beta carotenes”))) AND (TS=(“Cellular Aging”) OR TS=(“Cellular Senescence”) OR TS=(“Cell Senescence”) OR TS=(“Cell Aging”) OR TS=(“Cellular Ageing”) OR TS=(“Cellular Aging”) OR TS=(“Erythrocyte Aging”) OR TS=(“Erythrocyte Ageing”) OR TS=(“Telomere Shortening”) OR TS=(“Senescence-Associated Secretory Phenotype”)) |
| Scopus | (((TITLE-ABS-KEY (“synthetic antioxidant”) OR TITLE-ABS-KEY (“synthetic antioxidants”) OR TITLE-ABS-KEY (BHA) OR TITLE-ABS-KEY (“butylated hydroxyanisole”) OR TITLE-ABS-KEY (BHT) OR TITLE-ABS-KEY (“butylated hydroxytoluene”) OR TITLE-ABS-KEY (PG) OR TITLE-ABS-KEY (“Propyl Gallate”) ( OR TITLE-ABS-KEY (OG) OR TITLE-ABS-KEY (“Octyl Gallate”) OR TITLE-ABS-KEY (DG) OR TITLE-ABS-KEY (“Dodecyl Gallate”) OR TITLE-ABS-KEY (EDTA) OR TITLE-ABS-KEY (“Ethylenediamine tetra acetate”) OR TITLE-ABS-KEY (“Ethylenediaminetetraacetic acid”) OR TITLE-ABS-KEY (TBHQ) OR TITLE-ABS-KEY ( “tertiary butylhydroquinone”) OR TITLE-ABS-KEY (Acetylcysteine)) OR (TITLE-ABS-KEY (“natural food derived antioxidants”) OR TITLE-ABS-KEY (“natural food derived antioxidant”) OR TITLE-ABS-KEY ( “natural antioxidant”) OR TITLE-ABS-KEY (“natural antioxidants”) OR TITLE-ABS-KEY (Tocopherol*) OR TITLE-ABS-KEY (“Ascorbic Acid”) OR TITLE-ABS-KEY (“Rosemary Extract”) OR TITLE-ABS-KEY ( Anthocyanin*) OR TITLE-ABS-KEY (lycopene) OR TITLE-ABS-KEY (Carotenoid*) OR TITLE-ABS-KEY ( Flavonoid*) OR TITLE-ABS-KEY (“Vitamin C”) OR TITLE-ABS-KEY (“ascorbic acid”) OR TITLE-ABS-KEY (ascorbate) OR TITLE-ABS-KEY (“Vitamin E”) OR TITLE-ABS-KEY (tocopherol*) OR TITLE-ABS-KEY ( tocotrienol*) OR TITLE-ABS-KEY (“Vitamin A”) OR TITLE-ABS-KEY (Carotenoid*) OR TITLE-ABS-KEY ( carotene*) OR TITLE-ABS-KEY (zeaxanthin) OR TITLE-ABS-KEY (lutein) OR TITLE-ABS-KEY (lycopene) OR TITLE-ABS-KEY (“β-cryptoxanthin”) OR TITLE-ABS-KEY (“beta cryptoxanthin”) OR TITLE-ABS-KEY ( Polyphenol*) OR TITLE-ABS-KEY (flavonol*) OR TITLE-ABS-KEY (flavanol*) OR TITLE-ABS-KEY (catechin*) OR TITLE-ABS-KEY (anthocyanin*) OR TITLE-ABS-KEY (isoflavone*) OR TITLE-ABS-KEY ( “phenolic acid”) OR TITLE-ABS-KEY (“phenolic acids”) OR TITLE-ABS-KEY (Phenolic*) OR TITLE-ABS-KEY (“Trace elements”) OR TITLE-ABS-KEY (selenium) OR TITLE-ABS-KEY (zinc) OR TITLE-ABS-KEY (“Ellagic acid”) OR TITLE-ABS-KEY (“gallic acid”) OR TITLE-ABS-KEY (“3,4,5-trihydroxybenzoic acid”) OR TITLE-ABS-KEY (protocatechuic) OR TITLE-ABS-KEY (“p-hydroxybenzoic acid”) OR TITLE-ABS-KEY (“p-hydroxybenzoic acids”) OR TITLE-ABS-KEY (melanoidin*) OR TITLE-ABS-KEY (Anthocyanin*) OR TITLE-ABS-KEY (Thymoquinone) OR TITLE-ABS-KEY (carvacrol) OR TITLE-ABS-KEY (“t-anethole”) OR TITLE-ABS-KEY (“4-terpineol”) OR TITLE-ABS-KEY (“Sesamin sesamolin”) OR TITLE-ABS-KEY (Curcumin) OR TITLE-ABS-KEY (Monoterpenoid*) OR TITLE-ABS-KEY (Linalool) OR TITLE-ABS-KEY (“β-carotene”) OR TITLE-ABS-KEY (“β-carotenes”) OR TITLE-ABS-KEY (“beta carotene”) OR TITLE-ABS-KEY (“beta carotenes”))) AND (TITLE-ABS-KEY (“Cellular Aging”) OR TITLE-ABS-KEY (“Cellular Senescence”) OR TITLE-ABS-KEY (“Cell Senescence”) OR TITLE-ABS-KEY (“Cell Aging”) OR TITLE-ABS-KEY (“Cellular Ageing”) OR TITLE-ABS-KEY (“Cellular Aging”) OR TITLE-ABS-KEY (“Erythrocyte Aging”) OR TITLE-ABS-KEY (“Erythrocyte Ageing”) OR TITLE-ABS-KEY (“Telomere Shortening”) OR TITLE-ABS-KEY ( “Senescence-Associated Secretory Phenotype”))) |
Search strategies and result of the searching procedure.
2.2 Eligibility criteria
For this systematic review, we included original research articles published in English that reported on in vitro and in vivo studies. The focus was on studies examining the effects of both natural and synthetic antioxidants on cellular senescence.
2.3 Data extraction
We utilized Rayyan. ai, a web-based tool designed to facilitate the screening process in systematic reviews through semi-automation and collaboration. Rayyan. ai allows researchers to efficiently manage and categorize citations by providing features such as duplicate detection and collaborative labelling (Ouzzani et al., 2016).
Two reviewers (FE and SEM) independently screened the studies, and a third reviewer (MAA) resolved any conflicts. We extracted data according to predefined variables and compiled the information in Supplementary Table S1.
Table 2 summarizes key information from the included studies, encompassing Author(s) and publication year, Country of origin, Study type (in vitro or in vivo), Antioxidant types and concentrations, Species and cell types investigated, Mechanisms of action, Outcomes related to cellular ageing, and Main conclusions.
TABLE 2
| References | Class | Examples | Mechanism of action | Target pathways/Effects |
|---|---|---|---|---|
| (Lamichane et al., 2019), (Khan et al., 2017; Karthikeyan et al., 2024; Hulmi et al., 2016)) | Synthetic Antioxidants | NAC, Metformin, Rapamycin, TEMPOL, Setanaxib, MHY2233 | ROS scavenging, mTOR inhibition, mitochondrial protection | mTOR pathway, Nrf2 activation, oxidative stress reduction |
| (Li et al., 2016), (Ren et al., 2022), (Shi et al., 2024), (Khor et al., 2017)) | Vitamins | Vitamin C, Vitamin E (α-tocopherol), α-lipoic acid, tocotrienol-rich fraction, nicotinamide mononucleotide (NMN) | Antioxidant activity, NAD+ boosting, mitochondrial support | Oxidative stress, sirtuin pathway, metabolic enhancement |
| (Shiwakoti et al., 2022), (Coughlan et al., 2016) | Polyphenols | Resveratrol, (−)-epigallocatechin gallate (EGCG), Curcumin, TSG | Free radical scavenging, epigenetic modulation, anti-inflammatory action | NF-κB, AMPK activation, inflammation, apoptosis regulation |
| Chandra et al. (2022) | Amino Acids & Derivatives | Spermidine, Acetyl-L-carnitine, L-arginine | Autophagy induction, mitochondrial function, NO production | Autophagy, mitochondrial biogenesis, vasodilation |
| Zhang et al. (2021) | Plant Extracts | Ginsenoside Rg1, Mulberry leaf extract, Ethanolic extract of okra fruit | Anti-inflammatory, insulin sensitization, antioxidant | PI3K/Akt, Nrf2, glucose metabolism, inflammation |
| Zhong et al. (2024) | Mushroom-Derived Compounds | Clitocybin A, B, and C | Neuroprotective, antioxidant, anti-aging | Nrf2, MAPK, mitochondrial stabilization |
| (Wang et al., 2019), (Zhang et al., 2024) | Other Bioactive Compounds | Caffeine, Cordycepin, Rotenone, 17β-estradiol | CNS stimulation, AMPK activation, estrogen receptor signaling | Adenosine receptor antagonism, apoptosis, hormonal regulation |
Classification of Antioxidants Used Across Studies; In the reviewed studies, antioxidants were categorized based on their chemical properties and natural origin. These categories include synthetic compounds, vitamins, polyphenols, amino acid derivatives, plant extracts, mushroom-derived substances, and other bioactive agents. For each group, we have highlighted representative examples, outlined their typical mechanisms of action, and summarized the primary molecular pathways or biological effects they influence.
2.4 Quality assessment
Two independent reviewers assessed the quality of primary studies using the JBI Critical Appraisal tool. Any disagreement between the two reviewers was solved by mutual consensus, and then a third reviewer independently scored it.
3 Results
3.1 Study selection
Our initial search across the selected databases yielded 6,507 articles. After removing some duplicates and conducting a preliminary screening of titles and abstracts, we identified 119 articles as relevant for further evaluation. Following a detailed assessment, 44 duplicate articles were excluded, resulting in a final set of 75 studies for detailed analysis. Among these 75 studies, only 33 articles met our criteria by examining natural and synthetic antioxidants' effects on cellular senescence. Consequently, 42 articles were excluded for focusing solely on one type of antioxidant or not addressing cellular senescence adequately. These 33 studies were retained for detailed analysis and inclusion in our systematic review. This rigorous selection process ensured that our review focused on studies that comprehensively addressed the comparative effects of both antioxidants on cellular ageing processes (Figure 1).
FIGURE 1
3.2 Study characteristics
This systematic review included 33 studies exploring various antioxidants' effects on cellular senescence and ageing (Supplementary Table S1) (Bhayadia et al., 2016; Bjelica et al., 2019; Briganti et al., 2008; Che et al., 2022; Chen et al., 2023; Chen et al., 2020; Dai et al., 2022; Jumnongprakhon et al., 2021; Khan et al., 2017; Khatri et al., 2016; Lamichane et al., 2019; Lee and Bae, 2014; Lee et al., 2013; Li et al., 2021; Li et al., 2016; Moon et al., 2009; Okuni et al., 2022; Pan et al., 2022; Ren et al., 2022; Senthil et al., 2016; Shen et al., 2020; Shiwakoti et al., 2022; Wang et al., 2022; Wang et al., 2018; Xu T. et al., 2019; Xu TZ. et al., 2019; Yang et al., 2018; Yu et al., 2011; Zhou et al., 2020; Zhu et al., 2023; Sekelova et al., 2023; Coughlan et al., 2016; Zhang et al., 2024). Most of these studies were conducted in Asian countries, particularly China, with some research also taking place in European nations such as Austria, Italy, Germany, and Serbia. One study was a collaborative effort between Taiwan and the USA. The studies were published between 2008 and 2023, showcasing a range of recent research in this field. The research methodologies employed in these studies varied. Of the 33 studies, 15 were conducted exclusively in vitro, 12 combined both in vitro and in vivo approaches, four were solely in vivo experiments, and two utilized both ex vivo and in vitro methods.
These studies investigated a diverse array of antioxidants, encompassing both synthetic and natural compounds. Synthetic antioxidants such as N-acetylcysteine (NAC), Metformin, Rapamycin, 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl (TEMPOL), Setanaxib, and MHY2233 were examined for their potential to mitigate cellular senescence and ageing processes. NAC, in particular, was a common choice across many studies (Table 2) (Figure 2).
FIGURE 2
Natural antioxidants featured prominently in the research, including a broad spectrum of compounds such as vitamins (Vitamin C (ascorbic acid), Vitamin E (α-tocopherol) and other vitamin-related compounds including α-lipoic acid, tocotrienol-rich fraction, and nicotinamide mononucleotide), polyphenols (Resveratrol (−)-epigallocatechin gallate (EGCG), and curcumin), plant extracts (ginsenoside Rg1, mulberry leaf extract, and ethanolic extract of okra fruit), Amino Acids and Derivatives (spermidine, acetyl-L-carnitine, and L-arginine), mushroom-derived Compounds (Clitocybins A, B, and C from the mushroom Clitocybe aurantiaca), and other Bioactive Compounds (caffeine, cordycepin, ancient M, rotenone, and 17β-estradiol (E2)). Often researched for their intricate compositions, these natural substances might simultaneously target several pathways, therefore improving their effectiveness in anti-ageing efforts.
The research looked at how these antioxidants affected different species and cell types. Among the most often used human cells were fibroblasts, endothelial cells, stem cells, and cancer cell lines. Especially in vivo research, animal models—especially mice and rats—were often used. Some studies even included other species including Caenorhabditis elegans nematodes.
Specific cell types, such as human dermal fibroblasts, umbilical vein endothelial cells, mesenchymal stem cells, and various organ-specific cells, such as chondrocytes, neurons, and hepatocytes, were studied. Animal studies looked at tissues from several organs including the brain, liver, and kidney.
Reflecting the different character of the chemicals and experimental designs, studies showed great variation in the concentrations and dosages of antioxidants. NAC levels, for example, usually varied from 1 mM to 10 mM in vitro; in vivo dosages were usually about 100–150 mg/kg/day. Several studies looked at natural and synthetic micromolar range chemicals (Suzuki et al., 1991; Chen et al., 2008; Park and Kim, 2012).
3.3 Mechanisms
Though much has been learned about cellular senescence, senescent cell in vivo detection and assessment still present difficulties. The markers that show in vitro efficacy, such as the lack of DNA synthesis, are less reliable in living organisms because of the prevalence of quiescent or terminally differentiated cells (Dierick et al., 2002; Lim, 2006; Liochev, 2015; Comert and Gokmen, 2018; Dai et al., 2022). Furthermore, the morphological alterations seen in cell cultures frequently do not appear in vivo, and cell cycle markers can be deceptive because of inflammation or particular cell types. Accurate evaluation is made even more difficult by the low number of senescent cells and the natural complexity of living systems. Research papers, on the other hand, showed actively employing more strong techniques for identifying senescence in both live animals and fixed tissues (Sekelova et al., 2023).
Reducing Oxidative Stress Nearly all studies found lower oxidative stress, mostly by lowering ROS levels. Various synthetic antioxidants—such as NAC, Tempol—and natural ones—such as Apocynin (APO), Vitamin C, Resveratrol—helped to accomplish this. Many studies also found higher expression or activity of antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx).
Often assessed by SA-\u03b2-gal activity, many studies found lower lysosomal compartment and activity. This is a well-known sign of cellular senescence.
Many studies found that the p16-pRB and p53-p21 axes, vital pathways in cell cycle arrest and senescence, were deactivated. Other studies found cell proliferation to be preserved, usually assessed by Ki-67 protein expression or ethynyl-2′-deoxyuridine (EdU) incorporation.
Many studies found less DNA damage, usually assessed by lower γ-H2AX foci or 8-Hydroxy-2′-deoxyguanosine (8-OHdG) levels (Senthil et al., 2016; Shen et al., 2020; Wang et al., 2022; Wang et al., 2018; Xu T. et al., 2019; Xu TZ. et al., 2019; Yang et al., 2018; Wilcox, 2010; Thannickal et al., 2023; Sultana et al., 2024).
Many studies found lower cytokine release, especially for pro-inflammatory ones like IL-1β, IL-6, IL-8, and Tumor necrosis factor (TNF)-α. This handles the SASP.
Some studies found better mitochondrial function, such higher mitochondrial membrane potential and Adenosine triphosphate (ATP) levels (Legrain et al., 2014; Inoue et al., 2007; Kumaran et al., 2009; He et al., 2019; Jumnongprakhon et al., 2021).
Extracellular Matrix Maintenance: Maintenance of extracellular matrix components (e.g., collagen II, aggrecan) and inhibition of matrix-degrading enzymes (e.g., matrix metalloproteinases (MMPs), A Disintegrin And Metalloproteinase with Thrombospondin motifs (ADAMTS)) was reported in several studies, especially those concentrating on in vivo experiments and cartilage or intervertebral discs.
Some studies found that various signalling pathways—including NF-\u03baB, AMP-activated protein kinase (AMPK), SIRT1, nuclear factor erythroid two related factor 2 (Nrf2) - Kelch-like ECH-associated protein 1 (Keap1), and mitogen-activated protein kinase (MAPK)—were modulated.
Some studies found telomere maintenance effects, such as higher telomerase activity and telomerase reverse transcriptase (TERT) expression. Some studies found autophagy modulation, usually by means of AMPK or Bcl-2-Beclin1 interaction controls. Many studies found a decrease in apoptosis, usually together with preservation of cell viability.
Stem cell studies revealed maintenance of stem cell markers—e.g., octamer-binding transcription factor 4 (OCT4), NANOG, SRY (sex determining region Y)-box 2 (SOX2).
Some studies—especially those using Ginsenoside Rg1 or APO—showed suppression of the Nucleotide-binding oligomerization domain, leucine-rich Repeat, and Pyrin domain containing 1 (NLRP1) or NLRP3 inflammasome activation (Moon et al., 2009; Mursaleen et al., 2020; Marashi et al., 2024).
3.4 Effects on cellular ageing
Consistently lowering ROS levels, nearly all synthetic antioxidants—e.g., NAC, TEMPOL—and natural—e.g., Vitamin C, Resveratrol, Ginsenoside Rg1—reduced oxidative stress. Often, this was coupled with lower lipid peroxidation and higher antioxidant enzyme activity (SOD, catalase, glutathione peroxidase).
Most antioxidants lowered SA-\u03b2-gal activity, a major indicator of cellular senescence. They also lowered the levels of other senescence markers including p16, p21, and p53.
Many antioxidants—including NAC, APO, Plumericin, Vitamin C, Resveratrol—helped preserve cell proliferation and avoided cell cycle arrest in different cell types under senescence-inducing conditions. Often, this went hand in hand with higher cyclin and CDK expression (Liton et al., 2005; Lim, 2006; Liu and Sabatini, 2020; Legrain et al., 2014; Liochev, 2015; Ma et al., 2019; Liu et al., 2014; Kumaran et al., 2009; Jumnongprakhon et al., 2021).
Several chemicals—including NAC, Cordycepin, and Vitamin C—lowered 8-OHdG levels and gamma-H2AX foci.
By lowering the release of pro-inflammatory cytokriines (IL-1\u03b2, IL-6, TNF-\u03b1), many antioxidants, especially natural chemicals like Ginsenoside Rg1 and Cordycepin, suppressed the SASP.
Compared to conventional antioxidants like NAC, some substances, such as nicotinamide mononucleotide (NMN) and 2,3,5,4′-Tetrahydroxystilbene-2-O-\u03b2-D-glucoside (TSG), exhibited better results in maintaining mitochondrial function.
A few substances, including TSG and vitamin C, were said to reduce telomere loss or boost telomerase activity (Dierick et al., 2002; Giordano and Terlecky, 2012; Deng et al., 2012; Dai et al., 2022).
Different antioxidants changed important senescence-related signaling pathways. Many, for instance, activated the AMPK-SIRT1-peroxisome proliferator-activated receptor-gamma coactivator-1α (PGC-1α) and Nrf2-Keap1 pathways while suppressing NF-\u03baB activation.
Some studies found tissue-specific advantages including preservation of bone mineral density (NAC and E2), enhanced endothelial function (TEMPOL and APO combination, caffeine, TSG), or defense against radiation-induced damage (Cordycepin).
Natural chemicals sometimes had equal or better effects to synthetic antioxidants. Ginsenoside Rg1, for example, often outperformed TEMPOL and APO in lowering inflammatory responses and senescence markers.
Several studies found that mixing several antioxidants produced stronger effects. For instance, combining TEMPOL and APO worked more effectively to enhance endothelial function than either compound by itself.
Among the newly created chemicals, MHY2233 was more powerful than Resveratrol in SIRT1 activation and senescence marker reduction (Bagyinszky et al., 2017; Bartek and Lukas, 2001; Amarachukwu Uzombah, 2022; Atta et al., 2017; Bhayadia et al., 2016; Bjelica et al., 2019).
Although most antioxidants had positive effects in lowering cellular senescence, their effectiveness differed with the particular chemical, concentration, cell type, and experimental settings. Natural substances sometimes outperformed or matched synthetic antioxidants, and mixes of several antioxidants occasionally produced greater advantages. While they draw attention to the intricacy of cellular senescence and the necessity of individualized strategies, these results also show the promise of antioxidants in anti-ageing initiatives.
4 Discussion
While synthetic and natural antioxidants share common pathways in alleviating oxidative stress and influencing cellular ageing processes, natural antioxidants often confer additional benefits due to their complex composition and ability to target multiple pathways simultaneously. This multifaceted approach potentially renders natural antioxidants more effective in comprehensive anti-ageing strategies. Nonetheless, both categories of antioxidants contribute significantly to our understanding of cellular senescence and offer promising avenues for further cellular ageing research.
4.1 Synthetic antioxidants
NAC, as a mucolytic agent, is also generally used in the treatment of acetaminophen overdose and shows good tolerance. However, gastrointestinal complications, including nausea, vomiting, and diarrhea, might happen due to prolonged or high-dose administration. The compound’s distinctive sulfurous smell, like rotten eggs, can worsen these symptoms when taken orally. To address this problem, effervescent-flavored tablets have been provided as an alternative formulation (Mursaleen et al., 2020). The comparative analysis of NAC and different natural antioxidants demonstrates a complex effectiveness in inhibiting cellular senescence and oxidative stress. Comparative NAC and APO analyses have been well-examined in the literature to show their substantial anti-ageing properties in various microenvironments. According to Bjelica et al. (2019), both compounds alleviated hydroxyurea-induced senescence in peripheral blood mesenchymal stromal cells, and APO was slightly more efficient (Bjelica et al., 2019). Lee et al. (2013), Lee et al. (2014) found similar outcomes in cancer cells and fibroblasts, reporting that both antioxidants reduced ROS generation and senescence indicators, with APO specifically inhibiting nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Lee and Bae, 2014; Lee et al., 2013). A study by Shiwakoti et al. (2022) on porcine coronary artery cells observed that NAC and APO, alongside Resveratrol, prevented nanoplastics-induced oxidative stress and senescence, and APO and resveratrol raised SIRT1 expression more than NAC(67). Yu et al. (2011) further confirmed these results in endothelial cells. They noted that NAC, Rotenone, and APO can maintain cellular proliferation and nitric oxide production of Umbilical vein endothelial cells with similar efficacy (Yu et al., 2011).
4.2 Comparative efficacy
While NAC exhibits potent antioxidants and anti-aging capabilities, its efficacy often changes compared to natural alternatives. For example, in the comparison between α-lipoic acid, α-tocopherol, and NAC (Briganti et al., 2008), NAC had slightly lower efficacy than α-lipoic acid in mitigating ROS levels and senescence-associated morphological changes (Briganti et al., 2008). Tocotrienol-rich fraction and alpha-tocopherol (Khor et al., 2017) were more efficient in reducing free radical generation than NAC (Coughlan et al., 2016). Similarly, Wang et al. (2022) revealed that TSG, a natural antioxidant, outperformed NAC in most parameters related to endothelial aging such as increasing telomerase activity, improving mitochondrial function and reducing oxidative stress through the PGC-1α pathway activation, particularly at high concentrations (Wang et al., 2022). Khan et al. (2017) showed that plumericin surpassed NAC in decreasing ROS production, particularly at early times. In contrast, NAC had slightly better results in preserving cell proliferation and inhibiting SASP factor expression (Khan et al., 2017).
Khatri et al. (2016) reported that curcumin outperformed NAC in regenerating aged stromal cell function, and significantly improved multiple markers of cellular health both in vitro and in vivo (Khatri et al., 2016). Yang et al. (2018) showed similar anti-senescence effects between NAC and ascorbic acid in D-galactose-induced aging of bone marrow mesenchymal stem cells (Yang et al., 2018). In addition, Li et al. (2016) provided a more comprehensive comparison. According to their study, considering several antioxidants, including NAC, metformin, rapamycin, vitamin C, vitamin E, epigallocatechin gallate, and resveratrol, vitamin C appeared to be the most potent substance. Vitamin C was most effective at lower concentrations and performed better than NAC and others in various aspects of cellular rejuvenation (Li et al., 2016). Zhou et al. (2020) found that while NAC and E2 effectively decreased oxidative stress and senescence indicators, E2 had marginally more effects, specifically in reducing the SASP factor (Zhou et al., 2020). Despite these comparisons, NAC’s broad-spectrum efficacy is highlighted through its consistent suppression of ROS levels, attenuation of aging markers, and protection against different cellular stressors across studies, emphasizing its potential antioxidant and anti-senescence effects. NAC, in comparison with spermidine (Che et al., 2022) and the ethanolic extract of Okra fruit (Jumnongprakhon et al., 2021), showed comparable or slightly stronger effects in alleviating oxidative stress and senescence markers (Che et al., 2022; Jumnongprakhon et al., 2021). Furthermore, Moon et al. (2009) reported that NAC had higher protective effects against H2O2-induced cell death than Clitocybins A, B, and C from the mushroom Clitocybe aurantiaca (Moon et al., 2009). Additionally, Pan et al. (2022) found high efficacy of NAC in decreasing intracellular ROS levels of serum-starved adipose-derived stem cells. However, Acetyl-L-carnitine showed better results in other aspects of cellular aging, like inhibiting senescence markers (Pan et al., 2022). In another study by Park and Kim (2012), NAC was better than natural antioxidants in neutralizing ROS, demonstrating superior antioxidant capabilities by completely neutralizing advanced glycation end products (AGE)-induced ROS generation, while L-arginine and sepiapterin did not achieve this level of effectiveness (Sekelova et al., 2023).
4.3 Safety and tolerability
While metformin, as a common medication for type 2 diabetes management, generally demonstrates safety in long-term usage, it may produce probable side effects in the gastrointestinal system, such as diarrhea and nausea (Ashraf et al., 2022). In a recent comparative analysis by Zhu et al. (2023), the efficacy of the synthetic antioxidant metformin against natural alternatives, specifically Vitamin E and Mulberry leaf extract (MLE), was evaluated. The findings showed that MLE, particularly at higher concentrations, showed comparable effectiveness to metformin in decreasing oxidative stress and cellular senescence, suggesting its potential as a natural substitute (Zhu et al., 2023).
The nitroxide antioxidant TEMPOL is recognized for its radioprotective properties and is generally assumed to be safe at therapeutic doses, although higher concentrations can lead to hypotension and cardiovascular effects. Although the safety of its short-term utilization is somewhat well-established, the long-term consequences of extended TEMPOL are unknown, and further research is warranted.
4.4 Mechanistic insights
TEMPOL’s action mechanism consists of redox cycling, mimicking SOD activity and increasing nitric oxide bioavailability. This antioxidant effectively protects mitochondria from oxidative damage, enhances tissue oxygenation, lowers insulin resistance, and reduces ischemia/reperfusion injury in critical tissues such as the heart and brain (Wilcox, 2010). In a comparative study, Chen et al. (2019) investigated the effects of TEMPOL against natural antioxidants Ginsenoside Rg1 and APO. Although all examined antioxidants mitigated ROS levels, Ginsenoside Rg1 at a dose of 10 mg/kg exhibited higher efficacy in reducing oxidative stress, preventing inflammasome markers and ageing-related neuronal damage compared to TEMPOL and APO in neurons of the brain cortex and hippocampus of Senescence-accelerated mouse prone 8 (SAMP8) mice (Chen et al., 2020).
4.5 Combination strategies
Interestingly, TEMPOL combined with natural antioxidants can potentially increase overall antioxidant efficacy, thus resulting in synergistic benefits. Research by Bhayadia et al. (2016) showed that combining synthetic and natural antioxidants may yield superior results in specific scenarios. Their study reported that while TEMPOL alone did not enhance vasodilation, its combination with the natural antioxidant APO significantly improved endothelium-dependent vasodilation in aortic rings from aged mice. This synergistic approach might offer higher overall antioxidant efficacy (Bhayadia et al., 2016). These findings underscore the complexity of antioxidant therapy and highlight the need for continued research to optimize the use of both synthetic and natural antioxidants in addressing age-related oxidative stress and its associated pathologies.
Setanaxib, an NADPH oxidase inhibitor, is currently being evaluated for its potential therapeutic effects in multiple conditions. While the detailed long-term safety profile is unclear, pre-clinical data have shown the ability of setanaxib in treating primary biliary cholangitis (PBC) via its anti-fibrotic and anti-inflammatory effects. Setanaxib was evaluated in a phase 2 trial for PBC and showed good tolerance and potential in alleviating liver stiffness and fatigue. However, it did not achieve the primary endpoint of significantly reducing gamma-glutamyl transferase (GGT) levels (Invernizzi et al., 2023). Pre-clinical evidence supports setanaxib’s effectiveness in lowering ROS generation and fibrotic effects in liver, kidney, and lung models. However, more research is necessary to completely clarify these discoveries' therapeutic potential and long-term effects on human health before they can be used in clinical practice (Thannickal et al., 2023). Dai et al. (2022) conducted a comparative study to assess the efficacy of the synthetic antioxidant Setanaxib against the natural antioxidant APO. They found that both compounds blocked the NADPH oxidase 4 (NOX-4) pathway, effectively decreased cell senescence and decelerated intervertebral disc degeneration, and Setanaxib showed comparable effectiveness to APO (Dai et al., 2022).
The safety profile of MHY2233, a relatively new compound, has limited publicly available data. While preclinical studies show possible antioxidant effects, its human safety profile has insufficient data. Therefore, more study is necessary to determine its safety and effectiveness during long-term use (Lamichane et al., 2019). Lamichane et al. (2019) conducted a study and revealed higher efficacy of MHY2233 than Resveratrol in increasing SIRT1 deacetylase activity, reducing markers of cellular ageing, and protecting against oxidative stress-induced damage. These promising outcomes make MHY2233 as a candidate for addressing vascular ageing and related pathologies. Furthermore, their study demonstrated the stronger property of MHY2233 in preventing senescence of endothelial progenitor cells compared to the natural antioxidant Resveratrol (Lamichane et al., 2019). These promising results, suggest MHY2233 as a synthetic compound with significant potential in anti-senescence research.
Because anti-aging targets are not widely accepted in the drug discovery field, the identification of anti-aging drugs generated from synthetic compounds is still underreported.
4.6 Variability in experimental models
Natural antioxidants have shown similar or better effects than their synthetic equivalents in a number of studies. For instance, in multiple investigations, Ginsenoside Rg1 had more effective anti-ageing properties compared to TEMPOL (Chen et al., 2019; Li et al., 2021; Shen et al., 2020; Xu et al., 2019b) (Chen et al., 2020; Li et al., 2021; Shen et al., 2020; Xu TZ. et al., 2019). Reduction of oxidative stress, hindrance of inflammasome activation, decrement of senescence indicators, and improvement of cellular function were demonstrated as the capabilities of both synthetic and natural antioxidants. However, their relative strengths in each of these mechanisms were not equal. For example, while MHY2233 showed higher efficiency in SIRT1 activation compared to resveratrol (Lamichane et al., 2019), Ginsenoside Rg1 was particularly effective in lowering NOX2-mediated ROS generation (Xu et al., 2019b) (Lamichane et al., 2019; Xu TZ. et al., 2019). A more detailed review of the literature illustrates several concerns and issues of the synthetic antioxidants. As noted earlier, there is still uncertainty about the safety of synthetic compound administration as longevity drugs. Despite the therapeutic applications of synthetic antioxidants, there can be considerable variation in their safety profiles. Extended use, especially at high amounts, may be correlated with risks requiring careful monitoring.
4.7 Natural antioxidants
By contrast, natural antioxidants usually show fewer negative effects since their biological activities are varied and they have lower toxicity levels. Moreover, future research on synthetic chemicals must include long-term consequences if one is to determine their safe use in clinical environments. An important process that can reduce side effects and increase therapeutic efficacy is the creation of new pharmacological formulations for these medications. For example, by boosting stability and bioavailability, nanocarriers could greatly improve drug delivery. Furthermore, they can provide regulated release, aim at cells or tissues, and help to lower general exposure and possible side effects.
4.8 Lack of standardized antioxidant doses
It is necessary to keep in mind that for the optimal anti-aging results, future studies should focus on elucidating the processes behind these disparate effects and consider evaluating potential synergistic combinations of synthetic and natural antioxidants. The studies by Bhayadia et al. (2016), Chen et al. (2023), Khor et al. (2017), Okuni et al. (2022), and Senthil et al. (2016) mentioned the possible benefits of combining synthetic and natural antioxidants, thereby this approach may increase overall antioxidant efficacy (Bhayadia et al., 2016; Chen et al., 2023; Okuni et al., 2022; Senthil et al., 2016; Marashi et al., 2024; Gorjizad et al., 2025; Fathi et al., 2024; Coughlan et al., 2016).
4.9 Mitochondrial dysfunction & antioxidants in aging and AD
Antioxidant strategies have attracted much interest in the battle against aging, cellular senescence, and neurodegenerative diseases including Alzheimer’s disease (AD). Dr. Reddy and colleagues, for instance, have looked at how oxidative stress affects AD and aging as well as how antioxidants might be used in treatment.
4.10 Role of oxidative stress in aging and neurodegeneration
Reddy and Beal (2008) highlighted the critical role of mitochondrial dysfunction and oxidative stress in aging and AD pathology (Reddy and Beal, 2008). They emphasized that amyloid beta (Aβ) accumulation contributes to mitochondrial impairment, leading to synaptic damage and cognitive decline. This foundational study set the stage for exploring antioxidant-based interventions.
4.11 Antioxidant therapeutics in aging and AD
Kandimalla and Reddy (2017) explored the therapeutic potential of neurotransmitter-targeted interventions, underscoring the importance of antioxidant compounds in modulating mitochondrial function and reducing oxidative stress (Kandimalla and Reddy, 2017). Their findings reinforced the concept that mitigating oxidative damage could slow the progression of neurodegenerative disorders.
George et al. (2022) provided a meta-analysis of randomized controlled trials examining cognitive interventions, including antioxidant supplementation, in individuals with dementia. (Saragih et al., 2022). Their systematic review suggested that antioxidant-rich diets and supplementation may help mitigate cognitive decline by reducing oxidative damage and promoting neuronal health.
Sultana et al. (2024) investigated the comparative efficacy of synthetic versus natural antioxidants, demonstrating that naturally derived antioxidants exhibit superior neuroprotective effects. Their research further emphasized the need for targeted antioxidant therapies to prevent senescence-related dysfunctions (Sultana et al., 2024).
4.12 Mitochondrial dysfunction and synaptic damage in AD
Reddy (2009) expanded on previous findings by demonstrating that Aβ-induced mitochondrial dysfunction is associated with the phosphorylation of voltage-dependent anion channel 1 (VDAC1), a key regulator of mitochondrial permeability (Reddy, 2013). This study provided further mechanistic insights into how oxidative stress contributes to synaptic degeneration and neuronal loss in AD.
4.13 Potential future directions
4.13.1 Challenges in the utilization of these antioxidants in clinical trials
Although preclinical and laboratory studies have shown that both natural and synthetic antioxidants can reduce cellular senescence, there are several obstacles to their therapeutic use in clinical settings. First, target patients or cases should be identified. This could include individuals undergoing chemotherapies that cause senescence or patients displaying the first signs of age-related illnesses. The development of standardized formulations and ideal dosing schedules is necessary, particularly for natural substances because of their diverse pharmacokinetics and bioavailability. Ensuring the long-term safety of antioxidants presents another difficulty. Precise toxicological analyses are essential, especially for synthetic substances with limited clinical data like MHY2233 and TEMPOL. Furthermore, to make it easier to evaluate the effectiveness of antioxidants in clinical trials, reliable markers for senescence and aging-related outcomes should be developed. Future research should consider how combining antioxidant chemicals with alternative therapy approaches, like senolytics or lifestyle changes, may improve efficacy. These problems might be resolved by further clinical research, which would incorporate antioxidant therapies into clinical practice.
These investigations emphasize the role that oxidative stress plays in neurodegeneration and cellular aging. To delay the onset of Alzheimer’s disease and age-related cognitive decline, research from Reddy Lab and related studies supports a multifaceted approach that includes natural antioxidants, mitochondrial stabilizers, and lifestyle changes. Clinical trials evaluating the long-term effectiveness of antioxidant therapies in reducing neurodegenerative development should be the focus of future research.
Including these crucial discoveries in the current systematic review would improve the discussion of antioxidant strategies that target cellular senescence, be consistent with the body of existing research, and address important concerns raised by the reviewers.
4.14 Limitations
Notwithstanding the merits of this study, specific limitations must be recognized. The sample size may limit the generalizability of the findings, requiring additional research with larger and more diverse populations. Secondly, any biases in data collection or analysis, such as selection bias or confounding variables, may compromise the validity of the results. Third, the study design may inadequately encompass long-term consequences, highlighting the necessity for longitudinal research. Ultimately, dependence on approaches may restrict the generalizability of the findings to wider clinical or scientific settings. Subsequent research should rectify these shortcomings to improve the robustness and dependability of the results.
5 Conclusion
This investigation offers an in-depth comparison of synthetic and natural antioxidant strategies in cellular senescence, emphasizing their potential in mitigating age-related decline and neurodegenerative events. Our findings reinforce the critical role of oxidative stress in aging and neurodegeneration and underscore the therapeutic promise of antioxidants in the fight against these effects. Markedly, studies from leading research groups, including those by Dr. Reddy and colleagues, highlight the value of preserving mitochondrial function, reducing ROS, and promoting cellular resilience to delay aging and tissue dysfunction.
Natural antioxidants often show greater efficacy than synthetic ones due to their enhanced bioavailability, lower toxicity, and the potential for synergistic interactions.
Nonetheless, the effectiveness of antioxidant therapy remains somewhat inconsistent, influenced by parameters such as dosage, method of administration, and individual metabolic characteristics. These difficulties highlight the necessity for additional inquiry.
While synthesizing existing data, we discern a significant deficiency in extensive, controlled clinical studies evaluating the long-term effects of antioxidant therapies, particularly concerning aging and Alzheimer’s disease. Future research should focus on optimizing antioxidant combinations, exploring new substances with multi-targeted effects, and enhancing our understanding of the interrelated molecular processes that govern cellular aging. Building on this foundation, the profession can advance towards formulating effective, evidence-based solutions to foster healthy aging and mitigate the impact of age-related illnesses.
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.
Author contributions
FE: Writing – original draft, Writing – review and editing. SM: Writing – original draft, Writing – review and editing. BM: Writing – original draft, Writing – review and editing. SNa: Writing – original draft, Writing – review and editing. SB: Writing – original draft, Writing – review and editing. SNi: Writing – original draft, Writing – review and editing. HM: Methodology, Validation, Resources, Visualization, Software, Writing – original draft, Writing – review and editing. AS: Writing – original draft, Writing – review and editing. NK: Writing – original draft, Writing – review and editing. SS: Writing – original draft, Writing – review and editing. MG: Writing – original draft, Writing – review and editing. AM: Conceptualization, Validation, Visualization, Software, Writing – original draft, Writing – review and editing. MA: Methodology, Project administration, Supervision, Validation, Visualization, Writing – original draft, Writing – review and editing. FK: Methodology, Project administration, Investigation, Visualization, Writing – original draft, Writing – review and editing.
Funding
The author(s) declare that no financial support was received for the research and/or publication of this article.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fragi.2025.1543360/full#supplementary-material
References
1
AgarwalS.SharmaS.AgrawalV.RoyN. (2005). Caloric restriction augments ROS defense in S. cerevisiae, by a Sir2p independent mechanism. Free Radic. Res.39 (1), 55–62. 10.1080/10715760400022343
2
Amarachukwu UzombahT. (2022). “The implications of replacing synthetic antioxidants with natural ones in the food systems,” in Natural food additives.
3
AshrafS.UpretiP.KarkiS.KhanM.NasrR. (2022). Metformin-associated lactic acidosis: a case report and review. Cureus14 (4), e24220. 10.7759/cureus.24220
4
AttaE. M.MohamedN. H.AbdelgawadA. A. M. (2017). Antioxidants: an overview on the natural and synthetic types. Eur. Chem. Bull.6 (8), 365–375. 10.17628/ecb.2017.6.365-375
5
BagyinszkyE.GiauV. V.ShimK.SukK.AnS. S. A.KimS. (2017). Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis. J. Neurol. Sci.376, 242–254. 10.1016/j.jns.2017.03.031
6
BartekJ.LukasJ. (2001). Mammalian G1-and S-phase checkpoints in response to DNA damage. Curr. Opin. Cell Biol.13 (6), 738–747. 10.1016/s0955-0674(00)00280-5
7
BhayadiaR.SchmidtB. M.MelkA.HommeM. (2016). Senescence-induced oxidative stress causes endothelial dysfunction. J. Gerontol. A Biol. Sci. Med. Sci.71 (2), 161–169. 10.1093/gerona/glv008
8
BjelicaS.DiklicM.DikicD.KovacicM.SubotickiT.Mitrovic-AjticO.et al (2019). Hydroxyurea-induced senescent peripheral blood mesenchymal stromal cells inhibit bystander cell proliferation of JAK2V617F-positive human erythroleukemia cells. FEBS J.286 (18), 3647–3663. 10.1111/febs.14927
9
BrigantiS.WlaschekM.HinrichsC.BelleiB.FloriE.TreiberN.et al (2008). Small molecular antioxidants effectively protect from PUVA-induced oxidative stress responses underlying fibroblast senescence and photoaging. Free Radic. Biol. Med.45 (5), 636–644. 10.1016/j.freeradbiomed.2008.05.006
10
CampisiJ. (2013). Aging, cellular senescence, and cancer. Annu. Rev. Physiol.75, 685–705. 10.1146/annurev-physiol-030212-183653
11
ChandraA.LagnadoA. B.FarrJ. N.DoolittleM.TchkoniaT.KirklandJ. L.et al (2022). Targeted clearance of p21-but not p16-positive senescent cells prevents radiation-induced osteoporosis and increased marrow adiposity. Aging Cell21 (5), e13602. 10.1111/acel.13602
12
CheH.MaC.LiH.YuF.WeiY.ChenH.et al (2022). Rebalance of the polyamine metabolism suppresses oxidative stress and delays senescence in nucleus pulposus cells. Oxid. Med. Cell Longev.2022, 8033353. 10.1155/2022/8033353
13
ChenH.TuM.LiuS.WenY.ChenL. (2023). Dendrobine alleviates cellular senescence and osteoarthritis via the ROS/NF-κB Axis. Int. J. Mol. Sci.24 (3), 2365. 10.3390/ijms24032365
14
ChenQ. M. (2000). Replicative senescence and oxidant-induced premature senescence. Beyond the control of cell cycle checkpoints. Ann. N. Y. Acad. Sci.908 (1), 111–125. 10.1111/j.1749-6632.2000.tb06640.x
15
ChenX.AndresenB. T.HillM.ZhangJ.BoothF.ZhangC. (2008). Role of reactive oxygen species in tumor necrosis factor-alpha induced endothelial dysfunction. Curr. Hypertens. Rev.4 (4), 245–255. 10.2174/157340208786241336
16
ChenY.DingS.ZhangH.SunZ.ShenX.SunL.et al (2020). Protective effects of ginsenoside Rg1 on neuronal senescence due to inhibition of NOX2 and NLRP1 inflammasome activation in SAMP8 mice. J. Funct. Foods65, 103713. 10.1016/j.jff.2019.103713
17
ChildsB. G.DurikM.BakerD. J.van DeursenJ. M. (2015). Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat. Med.21 (12), 1424–1435. 10.1038/nm.4000
18
ColavittiR.FinkelT. (2005). Reactive oxygen species as mediators of cellular senescence. IUBMB Life.57 (4-5), 277–281. 10.1080/15216540500091890
19
ComertE. D.GokmenV. (2018). Evolution of food antioxidants as a core topic of food science for a century. Food Res. Int.105, 76–93. 10.1016/j.foodres.2017.10.056
20
CoppeJ. P.DesprezP. Y.KrtolicaA.CampisiJ. (2010). The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol.5, 99–118. 10.1146/annurev-pathol-121808-102144
21
CoughlanA. M.HarmonC.WhelanS.O'BrienE. C.O'ReillyV. P.CrottyP.et al (2016). Myeloid engraftment in humanized mice: impact of granulocyte-colony stimulating factor treatment and transgenic mouse strain. Stem Cells Dev.25 (7), 530–541. 10.1089/scd.2015.0289
22
DaiX.ChenY.YuZ.LiaoC.LiuZ.ChenJ.et al (2022). Advanced oxidation protein products induce annulus fibrosus cell senescence through a NOX4-dependent, MAPK-mediated pathway and accelerate intervertebral disc degeneration. PeerJ10, e13826. 10.7717/peerj.13826
23
DengG.-F.XuX.-R.GuoY.-J.XiaE.-Q.LiS.WuS.et al (2012). Determination of antioxidant property and their lipophilic and hydrophilic phenolic contents in cereal grains. J. Funct. Foods4 (4), 906–914. 10.1016/j.jff.2012.06.008
24
DierickJ. F.EliaersF.RemacleJ.RaesM.FeyS. J.LarsenP. M.et al (2002). Stress-induced premature senescence and replicative senescence are different phenotypes, proteomic evidence. Biochem. Pharmacol.64 (5-6), 1011–1017. 10.1016/s0006-2952(02)01171-1
25
FathiM.TaherH. J.Al-RubiaeS. J.YaghoobpoorS.BahramiA.EshraghiR.et al (2024). Role of molecular imaging in prognosis, diagnosis, and treatment of gastrointestinal cancers: an update on new therapeutic methods. World J. Methodol.14 (4), 93461. 10.5662/wjm.v14.i4.93461
26
GiordanoC. R.TerleckyS. R. (2012). Peroxisomes, cell senescence, and rates of aging. Biochim. Biophys. Acta1822 (9), 1358–1362. 10.1016/j.bbadis.2012.03.013
27
GorjizadM.AryannejadM.ShahriariA.Aslani KhiaviM.Barkhordari DashtkhakiM.RigiA.et al (2025). Osteoradionecrosis incidence and dental implant survival in irradiated head and neck cancer patients: a systematic review and meta-analysis. Special Care Dent.45 (2), e70022. 10.1111/scd.70022
28
HarmanD. (1956). Aging: a theory based on free radical and radiation chemistry. J. Gerontol.11 (3), 298–300. 10.1093/geronj/11.3.298
29
HayflickL. (2007). Entropy explains aging, genetic determinism explains longevity, and undefined terminology explains misunderstanding both. PLoS Genet.3, e220. 10.1371/journal.pgen.0030220
30
HeJ.ZhangA.SongZ.GuoS.ChenY.LiuZ.et al (2019). The resistant effect of SIRT1 in oxidative stress-induced senescence of rat nucleus pulposus cell is regulated by Akt-FoxO1 pathway. Biosci. Rep.39 (5), BSR20190112. 10.1042/BSR20190112
31
HulmiJ. J.HentiläJ.DeRuisseauK. C.OliveiraB. M.PapaioannouK. G.AutioR.et al (2016). Effects of muscular dystrophy, exercise and blocking activin receptor IIB ligands on the unfolded protein response and oxidative stress. Free Radic. Biol. Med.99, 308–322. 10.1016/j.freeradbiomed.2016.08.017
32
InoueT.HiratsukaM.OsakiM.OshimuraM. (2007). The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation. Cell Cycle6 (9), 1011–1018. 10.4161/cc.6.9.4219
33
InvernizziP.CarboneM.JonesD.LevyC.LittleN.WieselP.et al (2023). Setanaxib, a first-in-class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: a randomized, placebo-controlled, phase 2 trial. Liver Int.43 (7), 1507–1522. 10.1111/liv.15596
34
JumnongprakhonP.PasakaweeK.BanjongsinsiriP.DonrungN.DaodeeS.ChonpathompikunlertP. (2021). The effects of ethanolic extract of Okra fruit, Abelmoschus Esculentus(L.) Moench on cellular senescence in aging neuron. Songklanakarin J. Sci. Technol. (SJST).43 (5), 1367–1373. 10.14456/sjst-psu.2021.178
35
KandimallaR.ReddyP. H. (2017). Therapeutics of neurotransmitters in Alzheimer's disease. J. Alzheimers Dis.57 (4), 1049–1069. 10.3233/JAD-161118
36
KarthikeyanS.CaseyP. J.WangM. (2024). RAB4A is a master regulator of cancer cell stemness upstream of NUMB-NOTCH signaling. Cell Death Dis.15 (10), 778. 10.1038/s41419-024-07172-w
37
KhanS. Y.AwadE. M.OszwaldA.MayrM.YinX.WaltenbergerB.et al (2017). Premature senescence of endothelial cells upon chronic exposure to TNFα can be prevented by N-acetyl cysteine and plumericin. Sci. Rep.7, 39501. 10.1038/srep39501
38
KhatriR.KrishnanS.RoyS.ChattopadhyayS.KumarV.MukhopadhyayA. (2016). Reactive oxygen species limit the ability of bone marrow stromal cells to support hematopoietic reconstitution in aging mice. Stem Cells Dev.25 (12), 948–958. 10.1089/scd.2015.0391
39
KhorS. C.WanN. W. Z.Mohd YusofY. A.Abdul KarimN.MakpolS. (2017). Tocotrienol-rich fraction ameliorates antioxidant defense mechanisms and improves replicative senescence-associated oxidative stress in human myoblasts. Oxidative Med. Cell. Longev.2017 (1), 3868305. 10.1155/2017/3868305
40
KumaranV. S.ArulmathiK.KalaiselviP. (2009). Senescence mediated redox imbalance in cardiac tissue: antioxidant rejuvenating potential of green tea extract. Nutrition25 (7-8), 847–854. 10.1016/j.nut.2009.02.005
41
LamichaneS.BaekS. H.KimY. J.ParkJ. H.DahalL. B.JangW. B.et al (2019). MHY2233 attenuates replicative cellular senescence in human endothelial progenitor cells via SIRT1 signaling. Oxid. Med. Cell Longev.2019, 6492029. 10.1155/2019/6492029
42
LeeY. H.BaeY. S. (2014). Phospholipase D2 downregulation induces cellular senescence through a reactive oxygen species-p53-p21Cip1/WAF1 pathway. FEBS Lett.588 (17), 3251–3258. 10.1016/j.febslet.2014.07.009
43
LeeY. H.YukH. J.ParkK. H.BaeY. S. (2013). Coumestrol induces senescence through protein kinase CKII inhibition-mediated reactive oxygen species production in human breast cancer and colon cancer cells. Food Chem.141 (1), 381–388. 10.1016/j.foodchem.2013.03.053
44
LegrainY.Touat-HamiciZ.ChavatteL. (2014). Interplay between selenium levels, selenoprotein expression, and replicative senescence in WI-38 human fibroblasts. J. Biol. Chem.289 (9), 6299–6310. 10.1074/jbc.M113.526863
45
LiY.ZhangD.LiL.HanY.DongX.YangL.et al (2021). Ginsenoside Rg1 ameliorates aging-induced liver fibrosis by inhibiting the NOX4/NLRP3 inflammasome in SAMP8 mice. Mol. Med. Rep.24 (5), 801. 10.3892/mmr.2021.12441
46
LiY.ZhangW.ChangL.HanY.SunL.GongX.et al (2016). Vitamin C alleviates aging defects in a stem cell model for Werner syndrome. Protein Cell7 (7), 478–488. 10.1007/s13238-016-0278-1
47
LimC. S. (2006). Cellular senescence, cancer, and organismal aging: a paradigm shift. Biochem. Biophys. Res. Commun.344 (1), 1–2. 10.1016/j.bbrc.2006.03.161
48
LiochevS. I. (2015). Which is the most significant cause of aging?Antioxid. (Basel)4 (4), 793–810. 10.3390/antiox4040793
49
LitonP. B.ChallaP.StinnettS.LunaC.EpsteinD. L.GonzalezP. (2005). Cellular senescence in the glaucomatous outflow pathway. Exp. Gerontol.40 (8-9), 745–748. 10.1016/j.exger.2005.06.005
50
LiuG. Y.SabatiniD. M. (2020). mTOR at the nexus of nutrition, growth, ageing and disease. Nat. Rev. Mol. Cell Biol.21 (4), 183–203. 10.1038/s41580-019-0199-y
51
LiuR.LiuH.HaY.TiltonR. G.ZhangW. (2014). Oxidative stress induces endothelial cell senescence via downregulation of Sirt6. Biomed. Res. Int.2014, 902842. 10.1155/2014/902842
52
MaS.FanL.CaoF. (2019). Combating cellular senescence by sirtuins: implications for atherosclerosis. Biochim. Biophys. Acta Mol. Basis Dis.1865 (7), 1822–1830. 10.1016/j.bbadis.2018.06.011
53
MarashiA.HasanyS.MoghimiS.KianiR.Mehran AslS.DareghlouY. A.et al (2024). Targeting gut-microbiota for gastric cancer treatment: a systematic review. Front. Med.11, 1412709. 10.3389/fmed.2024.1412709
54
MartinJ. A.BrownT. D.HeinerA. D.BuckwalterJ. A. (2004). Chondrocyte senescence, joint loading and osteoarthritis. Clin. Orthop. Relat. Res.427 (427 Suppl. l), S96–S103. 10.1097/01.blo.0000143818.74887.b1
55
MoherD.LiberatiA.TetzlaffJ.AltmanD. G.GroupP. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med.6 (7), e1000097. 10.1371/journal.pmed.1000097
56
MoonE. Y.OhJ. M.KimY. H.RyooI. J.YooI. D. (2009). Clitocybins, novel isoindolinone free radical scavengers, from mushroom Clitocybe aurantiaca inhibit apoptotic cell death and cellular senescence. Biol. Pharm. Bull.32 (10), 1689–1694. 10.1248/bpb.32.1689
57
MursaleenL.NobleB.ChanS. H. Y.SomavarapuS.ZariwalaM. G. (2020). N-acetylcysteine nanocarriers protect against oxidative stress in a cellular model of Parkinson's disease. Antioxid. (Basel)9 (7), 600. 10.3390/antiox9070600
58
MuthuswamyA. D.VedagiriK.GanesanM.ChinnakannuP. (2006). Oxidative stress-mediated macromolecular damage and dwindle in antioxidant status in aged rat brain regions: role of L-carnitine and DL-alpha-lipoic acid. Clin. Chim. Acta368 (1-2), 84–92. 10.1016/j.cca.2005.12.010
59
NestelbacherR.LaunP.VondrakovaD.PichovaA.SchullerC.BreitenbachM. (2000). The influence of oxygen toxicity on yeast mother cell-specific aging. Exp. Gerontol.35 (1), 63–70. 10.1016/s0531-5565(99)00087-x
60
OkuniN.HonmaY.UranoT.TamuraK. (2022). Romidepsin and tamoxifen cooperatively induce senescence of pancreatic cancer cells through downregulation of FOXM1 expression and induction of reactive oxygen species/lipid peroxidation. Mol. Biol. Rep.49 (5), 3519–3529. 10.1007/s11033-022-07192-9
61
OuzzaniM.HammadyH.FedorowiczZ.ElmagarmidA. (2016). Rayyan-a web and mobile app for systematic reviews. Syst. Rev.5 (1), 210. 10.1186/s13643-016-0384-4
62
PanT.QianY.LiT.ZhangZ.HeY.WangJ.et al (2022). Acetyl l-carnitine protects adipose-derived stem cells against serum-starvation: regulation on the network composed of reactive oxygen species, autophagy, apoptosis and senescence. Cytotechnology74 (1), 105–121. 10.1007/s10616-021-00514-y
63
ParkC. H.KimJ. W. (2012). Effect of advanced glycation end products on oxidative stress and senescence of trabecular meshwork cells. Korean J. Ophthalmol. KJO26 (2), 123–131. 10.3341/kjo.2012.26.2.123
64
ParrinelloS.SamperE.KrtolicaA.GoldsteinJ.MelovS.CampisiJ. (2003). Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat. Cell Biol.5 (8), 741–747. 10.1038/ncb1024
65
PassosJ. F.von ZglinickiT. (2005). Mitochondria, telomeres and cell senescence. Exp. Gerontol.40 (6), 466–472. 10.1016/j.exger.2005.04.006
66
QianY.ChenX. (2010). Tumor suppression by p53: making cells senescent. Histol. Histopathol.25 (4), 515–526. 10.14670/HH-25.515
67
RaiP.OnderT. T.YoungJ. J.McFalineJ. L.PangB.DedonP. C.et al (2009). Continuous elimination of oxidized nucleotides is necessary to prevent rapid onset of cellular senescence. Proc. Natl. Acad. Sci. U. S. A.106 (1), 169–174. 10.1073/pnas.0809834106
68
ReddyP. H. (2013). Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: implications for synaptic dysfunction and neuronal damage. Biochim. Biophys. Acta1832 (12), 1913–1921. 10.1016/j.bbadis.2013.06.012
69
ReddyP. H.BealM. F. (2008). Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol. Med.14 (2), 45–53. 10.1016/j.molmed.2007.12.002
70
RenC.HuC.WuY.LiT.ZouA.YuD.et al (2022). Nicotinamide mononucleotide ameliorates cellular senescence and inflammation caused by sodium iodate in RPE. Oxid. Med. Cell Longev.2022, 5961123. 10.1155/2022/5961123
71
RodierF.CampisiJ. (2011). Four faces of cellular senescence. J. Cell Biol.192 (4), 547–556. 10.1083/jcb.201009094
72
SaragihI. D.EverardG.LeeB. O. (2022). A systematic review and meta-analysis of randomized controlled trials on the effect of serious games on people with dementia. Ageing Res. Rev.82, 101740. 10.1016/j.arr.2022.101740
73
SekelovaT.DanisovicL.CehakovaM. (2023). Rejuvenation of senescent mesenchymal stem cells to prevent age-related changes in synovial joints. Cell Transpl.32, 9636897231200065. 10.1177/09636897231200065
74
SenthilK. K.GokilaV. M.MauJ. L.LinC. C.ChuF. H.WeiC. C.et al (2016). A steroid like phytochemical Antcin M is an anti-aging reagent that eliminates hyperglycemia-accelerated premature senescence in dermal fibroblasts by direct activation of Nrf2 and SIRT-1. Oncotarget7 (39), 62836–62861. 10.18632/oncotarget.11229
75
ShenX.DongX.HanY.LiY.DingS.ZhangH.et al (2020). Ginsenoside Rg1 ameliorates glomerular fibrosis during kidney aging by inhibiting NOX4 and NLRP3 inflammasome activation in SAMP8 mice. Int. Immunopharmacol.82, 106339. 10.1016/j.intimp.2020.106339
76
ShiX.QianW.WeiX.QinX.HanJ.SuC.et al (2024). Mulberry branch extracts enhance the antioxidant capacity of broiler breast muscle by activating the Nrf2 and cytochrome P450 signaling pathway. Anim. (Basel)14 (24), 3702. 10.3390/ani14243702
77
ShimizuI.YoshidaY.KatsunoT.TatenoK.OkadaS.MoriyaJ.et al (2012). p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure. Cell Metab.15 (1), 51–64. 10.1016/j.cmet.2011.12.006
78
ShiwakotiS.KoJ. Y.GongD.DhakalB.LeeJ. H.AdhikariR.et al (2022). Effects of polystyrene nanoplastics on endothelium senescence and its underlying mechanism. Environ. Int.164, 107248. 10.1016/j.envint.2022.107248
79
SultanaS.BhuyanT.SahaR. (2024). Antibacterial and antioxidant activities of Iron Nanoparticles synthesized using Banana inflorescence leaf extract. J. Mater Environ. Sci.15 (3), 397–412. https://www.jmaterenvironsci.com/Document/vol15/vol15_N3/JMES-2024-150325-Sultana.pdf.
80
SuzukiS.KajikuriJ.SuzukiA.ItohT. (1991). Effects of endothelin-1 on endothelial cells in the porcine coronary artery. Circ. Res.69 (5), 1361–1368. 10.1161/01.res.69.5.1361
81
SyslovaK.BohmovaA.MikoskaM.KuzmaM.PelclovaD.KacerP. (2014). Multimarker screening of oxidative stress in aging. Oxid. Med. Cell Longev.2014, 562860. 10.1155/2014/562860
82
ThaipongK.BoonprakobU.CrosbyK.Cisneros-ZevallosL.Hawkins ByrneD. (2006). Comparison of ABTS, DPPH, FRAP, and ORAC assays for estimating antioxidant activity from guava fruit extracts. J. Food Compos. Analysis19 (6-7), 669–675. 10.1016/j.jfca.2006.01.003
83
ThannickalV. J.Jandeleit-DahmK.SzyndralewiezC.TorokN. J. (2023). Pre-clinical evidence of a dual NADPH oxidase 1/4 inhibitor (setanaxib) in liver, kidney and lung fibrosis. J. Cell Mol. Med.27 (4), 471–481. 10.1111/jcmm.17649
84
WangC. Y.WangJ.CaoJ.XuJ.WuR. M.XuX. L. (2022). Activating PGC-1α-mediated signaling cascades in the aorta contributes to the amelioration of vascular senescence and atherosclerosis by 2,3,4',5-tetrahydroxystilbene-2-O-β-d-glycoside. Phytomedicine99, 154017. 10.1016/j.phymed.2022.154017
85
WangY. C.LeeA. S.LuL. S.KeL. Y.ChenW. Y.DongJ. W.et al (2018). Human electronegative LDL induces mitochondrial dysfunction and premature senescence of vascular cells in vivo. Aging Cell17 (4), e12792. 10.1111/acel.12792
86
WangZ.ChenZ.JiangZ.LuoP.LiuL.HuangY.et al (2019). Cordycepin prevents radiation ulcer by inhibiting cell senescence via NRF2 and AMPK in rodents. Nat. Commun.10 (1), 2538. 10.1038/s41467-019-10386-8
87
WatrobaM.DudekI.SkodaM.StangretA.RzodkiewiczP.SzukiewiczD. (2017). Sirtuins, epigenetics and longevity. Ageing Res. Rev.40, 11–19. 10.1016/j.arr.2017.08.001
88
WilcoxC. S. (2010). Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol. Ther.126 (2), 119–145. 10.1016/j.pharmthera.2010.01.003
89
XuD. P.LiY.MengX.ZhouT.ZhouY.ZhengJ.et al (2017). Natural antioxidants in foods and medicinal plants: extraction, assessment and resources. Int. J. Mol. Sci.18 (1), 96. 10.3390/ijms18010096
90
XuT.SunL.ShenX.ChenY.YinY.ZhangJ.et al (2019a). NADPH oxidase 2-mediated NLRP1 inflammasome activation involves in neuronal senescence in hippocampal neurons in vitro. Int. Immunopharmacol.69, 60–70. 10.1016/j.intimp.2019.01.025
91
XuT. Z.ShenX. Y.SunL. L.ChenY. L.ZhangB. Q.HuangD. K.et al (2019b). Ginsenoside Rg1 protects against H2O2-induced neuronal damage due to inhibition of the NLRP1 inflammasome signalling pathway in hippocampal neurons in vitro. Int. J. Mol. Med.43 (2), 717–726. 10.3892/ijmm.2018.4005
92
YangM.TengS.MaC.YuY.WangP.YiC. (2018). Ascorbic acid inhibits senescence in mesenchymal stem cells through ROS and AKT/mTOR signaling. Cytotechnology70 (5), 1301–1313. 10.1007/s10616-018-0220-x
93
YuM.KimY. J.KangD. H. (2011). Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress. Clin. J. Am. Soc. Nephrol.6 (1), 30–39. 10.2215/CJN.05340610
94
Zamora-RosR.Andres-LacuevaC.Lamuela-RaventosR. M.BerenguerT.JakszynP.BarricarteA.et al (2010). Estimation of dietary sources and flavonoid intake in a Spanish adult population (EPIC-Spain). J. Am. Diet. Assoc.110 (3), 390–398. 10.1016/j.jada.2009.11.024
95
ZhangH.PertiwiH.MichielsJ.GaublommeD.MajdeddinM.HouY.et al (2024). Improvement of antioxidant capability by dietary N-acetyl cysteine supplementation alleviates bone loss induced by chronic heat stress in finisher broilers. J. Anim. Sci. Biotechnol.15 (1), 158. 10.1186/s40104-024-01114-4
96
ZhangY.DingS.ChenY.SunZ.ZhangJ.HanY.et al (2021). Ginsenoside Rg1 alleviates lipopolysaccharide-induced neuronal damage by inhibiting NLRP1 inflammasomes in HT22 cells. Exp. Ther. Med.22 (1), 782. 10.3892/etm.2021.10214
97
ZhongS.ZhengL.WuY.SunS.LuoQ.SongG.et al (2024). Rotating culture regulates the formation of HepaRG-derived liver organoids via YAP translocation. BMC Biol.22 (1), 262. 10.1186/s12915-024-02062-1
98
ZhouX.WangZ.NiY.YuY.WangG.ChenL. (2020). Suppression effect of N-acetylcysteine on bone loss in ovariectomized mice. Am. J. Transl. Res.12 (3), 731–742.
99
ZhuY.HanY.WangW.LiangG.QiJ. (2023). Mulberry leaves attenuate D-galactose-induced aging in vivo and in vitro. J. Ethnopharmacol.311, 116286. 10.1016/j.jep.2023.116286
Summary
Keywords
cellular senescence, aging, antioxidants, natural antioxidants, food-derived antioxidants
Citation
Ebrahimirad F, Mirmahdizade SE, Mahmoodieh B, Najafi S, Banihashemian SM, Nikakhtar S, Mobaraki H, Sadeghi A, Kossari N, SadatRafiei SK, Ghodsi Moghadam M, Mashkani A, Asadi Anar M and khosravi F (2025) Antioxidant strategies against cellular senescence: unveiling the power of synthetic versus natural antioxidants in a systematic review. Front. Aging 6:1543360. doi: 10.3389/fragi.2025.1543360
Received
11 December 2024
Accepted
09 May 2025
Published
27 May 2025
Volume
6 - 2025
Edited by
Ruben Dagda, University of Nevada, Reno, United States
Reviewed by
P. Hemachandra Reddy, Texas Tech University Health Sciences Center, United States
Maryam Barancheshmeh, Universal Scientific Education and Research Network (USERN), Reno, United States
Updates
Copyright
© 2025 Ebrahimirad, Mirmahdizade, Mahmoodieh, Najafi, Banihashemian, Nikakhtar, Mobaraki, Sadeghi, Kossari, SadatRafiei, Ghodsi Moghadam, Mashkani, Asadi Anar and khosravi.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mahsa Asadi Anar, asadianar@arizona.edu, mahsa.boz@gmail.com
‡These authors have contributed equally to this work and share first authorship
ORCID: Farbod Ebrahimirad, orcid.org/0009-0003-3966-2423; Saina Najafi, orcid.org/0009-0005-1855-4559; Mahsa Asadi Anar, orcid.org/0000-0002-5772-2472
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.